New nucleoside analogues in clinical development.

Stefan Faderl; Varsha Gandhi; Hagop Kantarjian; William Plunkett

New nucleoside analogues in clinical development.

Stefan Faderl, Varsha Gandhi, Hagop Kantarjian, William Plunkett

Research output: Contribution to journal › Review article › peer-review

Original language	English (US)
Pages (from-to)	37-58
Number of pages	22
Journal	Cancer chemotherapy and biological response modifiers
Volume	20
State	Published - 2002

ASJC Scopus subject areas

General Medicine

Cite this

@article{f1fd8919838a48febfbcee635413df6a,

title = "New nucleoside analogues in clinical development.",

author = "Stefan Faderl and Varsha Gandhi and Hagop Kantarjian and William Plunkett",

note = "Copyright: This record is sourced from MEDLINE{\textregistered}/PubMed{\textregistered}, a database of the U.S. National Library of Medicine",

year = "2002",

language = "English (US)",

volume = "20",

pages = "37--58",

journal = "Cancer chemotherapy and biological response modifiers",

issn = "0921-4410",

publisher = "Elsevier BV",

}

TY - JOUR

T1 - New nucleoside analogues in clinical development.

AU - Faderl, Stefan

AU - Gandhi, Varsha

AU - Kantarjian, Hagop

AU - Plunkett, William

N1 - Copyright: This record is sourced from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

PY - 2002

Y1 - 2002

UR - http://www.scopus.com/inward/record.url?scp=0038315227&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038315227&partnerID=8YFLogxK

M3 - Review article

C2 - 12703199

AN - SCOPUS:0038315227

SN - 0921-4410

VL - 20

SP - 37

EP - 58

JO - Cancer chemotherapy and biological response modifiers

JF - Cancer chemotherapy and biological response modifiers

ER -

New nucleoside analogues in clinical development.

ASJC Scopus subject areas

Other files and links

Cite this